Specific binding of thyroid-stimulating hormone by human serum globulins

Area of Science:

• Endocrinology
• Immunology
• Biochemistry

Background:

• Graves' disease is an autoimmune disorder characterized by elevated thyroid stimulating immunoglobulins (TSI).
• Understanding the interaction between TSI and thyrotropin (TSH) is crucial for elucidating disease mechanisms.

Purpose of the Study:

• To investigate the specific thyrotropin (TSH)-binding properties of globulin preparations from patients with Graves' disease and healthy individuals.
• To characterize the nature and affinity of TSH binding sites associated with TSI.

Main Methods:

• Testing globulin preparations from TSI-positive (Graves' disease) and TSI-negative (healthy) individuals for 131I-labelled TSH binding.
• Characterizing binding kinetics, affinity (Kd), maximum binding capacity (Bmax), and influencing factors (pH, incubation time).
• Utilizing chromatography (Sephadex G-200) and electrophoresis (paper electrophoresis) to identify the nature of binding macromolecules.

Main Results:

• Globulins from both patient and control groups demonstrated TSH binding sites.
• TSI-positive globulins exhibited two distinct binding patterns: A-type (similar to controls) and B-type (different affinity and capacity).
• TSH binding was associated with macromolecules migrating with immunoglobulin G (IgG) and was reversible.

Conclusions:

• Specific TSH binding sites are present in globulins from both Graves' disease patients and healthy individuals.
• A subset of Graves' disease patients possesses globulins with unique TSH-binding characteristics, potentially contributing to disease pathogenesis.
• The identified TSH binding sites are linked to immunoglobulin G, suggesting an autoimmune basis for this interaction.